Minogue Medical to Serve as Exclusive Canadian Distributor for ViewRay's MRIdian System
Cleveland, April 18, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company has partnered with Minogue Medical Inc., a leading Canadian distributor of surgical devices, operating room disposables, hospital equipment, and simulators for medical education. As part of the exclusive distribution agreement, Minogue Medical will market, sell, and support ViewRay's MRIdian MRI-guided radiation therapy system throughout Canada.
"The medical device market in Canada is strong and sophisticated, with a high demand for innovative medical technologies," said Jim Alecxih, Chief Commercial Officer at ViewRay. "We're pleased to partner with Minogue Medical to bring MRIdian to the Canadian healthcare system and improve the accuracy and precision of radiation therapy throughout the country."
Minogue Medical Inc., headquartered in Montreal, Quebec, is one the leading distributors of medical equipment in Canada. For more than 30 years, Minogue Medical has provided hospitals and medical clinics with value-driven, best-to-market products, and ensured continued assistance through a specialized field-based support team. The company's core values revolve around best patient care and delivery of state-of-the-art medical products.
"We are excited to continue to bring innovative technologies to Canadian hospitals and patients," said Danny Minogue, CEO of Minogue Medical Inc. "MRIdian's MRI-guided radiation therapy will help provide Canadians with accurate, efficient, optimized care to help ensure excellent outcomes for patients."
MRIdian provides continuous high-contrast imaging of soft tissue during radiation therapy treatment to help clinicians position the patient, track tumor and anatomical motion, and accurately target treatment. MRIdian also enables on-table adaptive therapy, which allows clinicians to adapt to changes and movement in the patient's anatomy in real-time while the patient is being treated, bringing even greater precision to radiation delivery.
ViewRay®, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purposely built to deliver high-precision radiation without unnecessary beam distortion, and consequently, help to mitigate skin toxicity and other safety concerns that may otherwise arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
Source ViewRay, Inc.
ViewRay Investor Contact: Michaella Gallina, Senior Director, Investor Relations and Communications, ViewRay, Inc., 1-844-MRIdian (674-3426), email@example.com
ViewRay Media Contact: Karen Hackstaff, Vice President, Strategy and Branding, ViewRay, Inc., 1-844-MRIdian (674-3426), firstname.lastname@example.org
Web Site: http://www.viewray.com